Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

SIO Corner

The Society of Interventional Oncology (SIO) is a non-profit association that supports and promotes the field of interventional oncology (IO). SIO members are invited to submit research highlights, clinical images, and reviews on IO-related topics. Submissions may be directed to our SIO Corner Section Editor, Elena Violari, at eviolari@live.com.

Katerina Lee, MD
Podcasts
Augmented Reality for Multi-Needle Composite Liver Tumor Ablation
06/20/2024
Katerina Lee, MD
Andrew Kolarich, MD
In this episode of the SIO Corner podcast, Katerina Lee, MD, discusses her study regarding the use of a smartphone augmented reality guidance system for composite ablation margins in phantom models.
In this episode of the SIO Corner podcast, Katerina Lee, MD, discusses her study regarding the use of a smartphone augmented reality guidance system for composite ablation margins in phantom models.
In this episode of the SIO...
06/20/2024
IO Learning
Dania Daye, MD, PhD, Massachusetts General Hospital
Podcasts
How Artificial Intelligence May Change Interventional Oncology
04/23/2024

Featuring Dania Daye, MD, PhD

Featuring Dania Daye, MD, PhD
Dania Daye, MD, PhD, joins this episode of the SIO Corner podcast to share insights on how AI can be used to improve clinical practice in interventional oncology and other medical fields.
Dania Daye, MD, PhD, joins this episode of the SIO Corner podcast to share insights on how AI can be used to improve clinical practice in interventional oncology and other medical fields.
Dania Daye, MD, PhD, joins this...
04/23/2024
IO Learning
Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
Addition of Durvalumab, Bevacizumab to TACE for Hepatocellular Carcinoma Improves PFS
01/23/2024

Featuring Riccardo Lencioni, MD

Featuring Riccardo Lencioni, MD ...
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology
Dr. Kavi Krishnasamy and Dr. Vijay Ramalingam
Podcast
SIO 2024 Preview: A Conversation With Conference Chair Vijay Ramalingam
01/03/2024
In this episode of the IOL Radio Podcast, Kavi Krishnasamy, MD, interventional radiologist at Columbia University Irving Medical Center, and his guest Vijay Ramalingam, MD, IR professional at Beth Israel Deaconess Medical Center, discuss the...
In this episode of the IOL Radio Podcast, Kavi Krishnasamy, MD, interventional radiologist at Columbia University Irving Medical Center, and his guest Vijay Ramalingam, MD, IR professional at Beth Israel Deaconess Medical Center, discuss the...
In this episode of the IOL Radio...
01/03/2024
IO Learning
Dr. AJ Gun, Dr. Christopher Malone
Podcast
Award-Winning Abstract From SIO 2023
06/30/2023
AJ Gunn, MD; Christopher Malone, MD
Dr Gunn and Dr Malone discuss Dr. Malone’s Award-Winning abstract from SIO 2023, the process of actualizing this study, and what to expect from Dr. Malone and his colleagues at SIO 2024.
Dr Gunn and Dr Malone discuss Dr. Malone’s Award-Winning abstract from SIO 2023, the process of actualizing this study, and what to expect from Dr. Malone and his colleagues at SIO 2024.
Dr Gunn and Dr Malone discuss...
06/30/2023
IO Learning
Dr Elena Violari and Dr Erica Alexander
Podcast
The SIO's Resident Medical Student Section Launch
06/20/2023

Dr Elena Violari and Dr Erica Alexander

Dr Elena Violari and Dr Erica Alexand...
Dr Violari and Dr Alexander discuss the launching of the SIO resident medical student section, a new opportunity developed by SIO for medical students to connect and collaborate.
Dr Violari and Dr Alexander discuss the launching of the SIO resident medical student section, a new opportunity developed by SIO for medical students to connect and collaborate.
Dr Violari and Dr Alexander...
06/20/2023
IO Learning
Lynn Savic, MD, PhD, and AJ Gunn, MD
Podcast
The SIO’s Talk Tuesday Educational Lecture Series
05/11/2023
Dr AJ Gunn and Dr Lynn Savic discuss the SIO’s Talk Tuesdays initiative, a virtual series that includes free educational lectures designed for trainees and early-career interventional radiologists.
Dr AJ Gunn and Dr Lynn Savic discuss the SIO’s Talk Tuesdays initiative, a virtual series that includes free educational lectures designed for trainees and early-career interventional radiologists.
Dr AJ Gunn and Dr Lynn Savic...
05/11/2023
IO Learning
Dr Elena Violari and Dr Constantinos Sofocleous
Podcast
The ACCLAIM Trial to Assess Microwave Ablation as the Standard of Care for Colorectal Liver Metastases
03/07/2023

Constantinos Sofocleous, MD, PhD, FSIR, FCIRSE

Constantinos Sofocleous, MD, PhD, FSI...
ACCLAIM, the first international trial launched by the SIO, assesses microwave ablation as the standard of care for colorectal liver mets. Study PI Constantinos Sofocleous provides an update on ACCLAIM, which recently enrolled its first...
ACCLAIM, the first international trial launched by the SIO, assesses microwave ablation as the standard of care for colorectal liver mets. Study PI Constantinos Sofocleous provides an update on ACCLAIM, which recently enrolled its first...
ACCLAIM, the first international...
03/07/2023
IO Learning
Violari and Bryce
Podcast
Percutaneous Locoregional Therapies for the Treatment of Breast Cancer
01/21/2023
Dr Elena Violari and Dr Yolanda Bryce discuss percutaneous locoregional therapies for the treatment of breast cancer.
Dr Elena Violari and Dr Yolanda Bryce discuss percutaneous locoregional therapies for the treatment of breast cancer.
Dr Elena Violari and Dr Yolanda...
01/21/2023
IO Learning
Dr Alan Sag
SIO2023 Highlights
Current Trends and Future Directions in Musculoskeletal Interventions
01/20/2023

Alan Alper Sag, MD, Assistant Professor, Duke Interventional Radiology and Duke Orthopaedic Surgery

Alan Alper Sag, MD, Assistant Profess...
Alan Alper Sag, MD, Assistant Professor, Duke Interventional Radiology and Duke Orthopaedic Surgery, discusses the current state and future of musculoskeletal interventions.
Alan Alper Sag, MD, Assistant Professor, Duke Interventional Radiology and Duke Orthopaedic Surgery, discusses the current state and future of musculoskeletal interventions.
Alan Alper Sag, MD, Assistant...
01/20/2023
IO Learning
Katerina Lee, MD
Podcasts
Augmented Reality for Multi-Needle Composite Liver Tumor Ablation
06/20/2024
Katerina Lee, MD
Andrew Kolarich, MD
In this episode of the SIO Corner podcast, Katerina Lee, MD, discusses her study regarding the use of a smartphone augmented reality guidance system for composite ablation margins in phantom models.
In this episode of the SIO Corner podcast, Katerina Lee, MD, discusses her study regarding the use of a smartphone augmented reality guidance system for composite ablation margins in phantom models.
In this episode of the SIO...
06/20/2024
IO Learning
Osman Ahmed, MD, University of Chicago Medicine
Videos
Histotripsy: Current and Future Applications
05/09/2024

Featuring Osman Ahmed, MD

Featuring Osman Ahmed, MD
Osman Ahmed, MD, gives an overview of histotripsy and explains the recent #HOPE4LIVER trial, looking the safety and efficacy of this technique for liver tumors.
Osman Ahmed, MD, gives an overview of histotripsy and explains the recent #HOPE4LIVER trial, looking the safety and efficacy of this technique for liver tumors.
Osman Ahmed, MD, gives an...
05/09/2024
IO Learning
Christos Georgiades, MD, PhD, Johns Hopkins Hospital
Videos
Physics of Histotripsy
05/09/2024

Featuring Christos Georgiades, MD, PhD

Featuring Christos Georgiades, MD, Ph...
Christos Georgiades, MD, PhD, explains the physics of histotripsy and how this technique differs from existing interventional oncology treatments.
Christos Georgiades, MD, PhD, explains the physics of histotripsy and how this technique differs from existing interventional oncology treatments.
Christos Georgiades, MD, PhD,...
05/09/2024
IO Learning
Dania Daye, MD, PhD, Massachusetts General Hospital
Podcasts
How Artificial Intelligence May Change Interventional Oncology
04/23/2024

Featuring Dania Daye, MD, PhD

Featuring Dania Daye, MD, PhD
Dania Daye, MD, PhD, joins this episode of the SIO Corner podcast to share insights on how AI can be used to improve clinical practice in interventional oncology and other medical fields.
Dania Daye, MD, PhD, joins this episode of the SIO Corner podcast to share insights on how AI can be used to improve clinical practice in interventional oncology and other medical fields.
Dania Daye, MD, PhD, joins this...
04/23/2024
IO Learning
Daniel B. Brown, MD, FSIR
Videos
Y90 Radioembolization for Patients With Hepatocellular Carcinoma Who Have Undergone Prior Resection
04/12/2024

Featuring Daniel B. Brown, MD, FSIR

Featuring Daniel B. Brown, MD, FSIR ...
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR,...
04/12/2024
IO Learning
AJ Gunn, MD, University of Alabama at Birmingham
Videos
Optimal Treatment of Patients With Central Renal Tumors
04/11/2024

Featuring AJ Gunn, MD

Featuring AJ Gunn, MD
At the 2024 SIR Annual Meeting, AJ Gunn, MD, University of Alabama at Birmingham, discussed treatment for patients with central renal tumors.
At the 2024 SIR Annual Meeting, AJ Gunn, MD, University of Alabama at Birmingham, discussed treatment for patients with central renal tumors.
At the 2024 SIR Annual Meeting,...
04/11/2024
IO Learning
Q&As
Compliance With Interventional Oncology Accreditation Standards Among Interventional Radiologists
03/25/2024

Featuring Murat Dökdök, MD

Featuring Murat Dökdök, MD
Dr Murat Dökdök discusses the importance of compliance with interventional oncology accreditation standards among interventional radiologists.
Dr Murat Dökdök discusses the importance of compliance with interventional oncology accreditation standards among interventional radiologists.
Dr Murat Dökdök discusses the...
03/25/2024
IO Learning
Constantino Peña, MD, Miami Cancer Institute
Videos
The Importance of a Multidisciplinary Approach in Interventional Oncology
03/21/2024

Featuring Constantino Peña, MD

Featuring Constantino Peña, MD ...
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses...
03/21/2024
IO Learning
Nadine Abi-Jaoudeh, MD, University of California, Irvine
Videos
Practical Pearls for DEB-TACE
03/13/2024

Featuring Nadine Abi-Jaoudeh, MD

Featuring Nadine Abi-Jaoudeh, MD ...
Nadine Abi-Jaoudeh, MD, shares her top clinical pearls for drug-eluting bead transarterial chemoembolization.
Nadine Abi-Jaoudeh, MD, shares her top clinical pearls for drug-eluting bead transarterial chemoembolization.
Nadine Abi-Jaoudeh, MD, shares...
03/13/2024
IO Learning
Rahul Sheth, MD, MD Anderson Cancer Center
Videos
The Role of Intratumoral Immunotherapy in Interventional Oncology
03/06/2024

Featuring Rahul Sheth, MD

Featuring Rahul Sheth, MD
Rahul Sheth, MD, explains the uses and limitations to immunotherapy within oncology and how intratumoral delivery of these agents may change the field of interventional oncology.
Rahul Sheth, MD, explains the uses and limitations to immunotherapy within oncology and how intratumoral delivery of these agents may change the field of interventional oncology.
Rahul Sheth, MD, explains the...
03/06/2024
IO Learning

SIO Session at CIO 2021: NCCN Guidelines

Where Does IO Stand in the NCCN Guidelines: Panel Discussion
02/16/2022
Where Does IO Stand in the NCCN Guidelines: Renal Cell Carcinoma
02/16/2022
Where Does IO Stand in the NCCN Guidelines: Lung and Metastases to the Lung
02/16/2022
Where Does IO Stand in the NCCN Guidelines: mNET and Other Tumor Types
02/16/2022
Where Does IO Stand in the NCCN Guidelines: mCRC
02/16/2022
Where Does IO Stand in the NCCN Guidelines: ICC
02/16/2022
Where Does IO Stand in the NCCN Guidelines: HCC
02/16/2022
Dr. David S. Wang
CIO Presentation
HCC: Year in Review With Dr. David S. Wang
11/09/2023
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang,...
11/09/2023
IO Learning
Callstrom CIO
Musculoskeletal Oncologic Interventions: 2022 Year in Review
Matthew Callstrom, MD, PhD presents notable 2022 studies on musculoskeletal interventions at the Symposium on Clinical Interventional Oncology.
01/06/2023
Ahmed CIO Video
Renal Ablation: 2022 Year in Review
Muneeb Ahmed, MD, FSIR presents notable 2022 studies on renal ablation at the Symposium on Clinical Interventional Oncology.
01/06/2023
Robert Suh
Lung Ablation: 2022 Year in Review
Robert Suh, MD presents notable 2022 studies on lung ablation at the Symposium on Clinical Interventional Oncology.
01/06/2023
Ganguli CIO
Y90 Update on Metastatic Disease: 2022 Year in Review
Suvranu Ganguli, MD, FSIR presents notable 2022 studies on Y-90 for metastatic disease at the Symposium on Clinical Interventional Oncology.
01/06/2023
Tabori CIO
Y90: 2022 Year in Review
Nora Tabori, MD presents notable Y-90 studies at the Symposium on Clinical Interventional Oncology in 2022.
01/06/2023
Dan Brown
Liver Metastatic Disease: 2022 Year in Review
Daniel Brown, MD, FSIR reviews noteworthy 2022 studies on liver metastatic disease at the Symposium on Clinical Interventional Oncology.
01/04/2023
Riad Salem, MD, MBA
HCC: 2022 Year in Review
Riad Salem, MD, MBA presents notable studies from 2022 at the Symposium on Clinical Interventional Oncology.
01/01/2023
Dr Abdel Aal
HCC Treatment Complicated by Pneumothorax
02/17/2022
Dr Prologo
Cement Placement Complicated by Extra Vertebral Body
02/17/2022

Subscribe

IO Learning Newsletter

News

SIO Talk Tuesdays with Rony Avritscher, MD, moderated by Brad Wood, MD, and Haley Leopold, MD RMSS Co-Moderator
News
Attend the First SIO Talk Tuesdays Event
06/06/2023
Washington, DC (6 June 2023) — Join SIO next Tuesday for the first Talk Tuesdays of the summer! The free virtual series of ducational lectures is designed to help you advance your career in interventional radiology. The series kicks off on...
Washington, DC (6 June 2023) — Join SIO next Tuesday for the first Talk Tuesdays of the summer! The free virtual series of ducational lectures is designed to help you advance your career in interventional radiology. The series kicks off on...
Washington, DC (6 June 2023) —...
06/06/2023
IO Learning
News
Society of Interventional Oncology Announces First Site Approved for Enrollment in ACCLAIM Clinical Trial
01/13/2023
Washington, DC (13 January 2023) – The Society of Interventional Oncology (SIO) proudly announces Mayo Clinic as the first site approved and activated for enrollment on the society’s primary clinical trial, “Ablation with...
Washington, DC (13 January 2023) – The Society of Interventional Oncology (SIO) proudly announces Mayo Clinic as the first site approved and activated for enrollment on the society’s primary clinical trial, “Ablation with...
Washington, DC (13 January 2023)...
01/13/2023
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
Allison Casey
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
News
Radiation Therapy May Be Potential Heart Failure Treatment
11/28/2023

Julia Evangelou Strait

Julia Evangelou Strait
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose...
11/28/2023
Cath Lab Digest
News
Canon Medical Introduces Alphenix Sky 12 HD Interventional System
09/12/2023
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) —...
09/12/2023
IO Learning

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement